The stock of Moolec Science SA (NASDAQ: MLEC) has increased by 21.97 when compared to last closing price of 1.41.Despite this, the company has seen a gain of 44.52% in its stock price over the last five trading days. Accesswire reported 2024-03-06 that LUXEMBOURG / ACCESSWIRE / March 6, 2024 / Moolec Science SA (NASDAQ:MLEC) (“Company”; “Moolec”), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today that it will release its Business Update for the Second Quarter Fiscal Year 2024 on Wednesday, March 13, 2024, before the market opens. logo Moolec’s Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra will host a live Conference Call on Wednesday, March 13, 2024, at 08:30 am ET.
Is It Worth Investing in Moolec Science SA (NASDAQ: MLEC) Right Now?
The 36-month beta value for MLEC is at -0.49. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MLEC is 3.58M, and currently, shorts hold a 0.14% of that float. The average trading volume for MLEC on April 18, 2024 was 16.89K shares.
MLEC’s Market Performance
MLEC’s stock has seen a 44.52% increase for the week, with a 14.65% rise in the past month and a -12.61% fall in the past quarter. The volatility ratio for the week is 9.23%, and the volatility levels for the past 30 days are at 9.08% for Moolec Science SA The simple moving average for the past 20 days is 30.81% for MLEC’s stock, with a -30.98% simple moving average for the past 200 days.
Analysts’ Opinion of MLEC
Many brokerage firms have already submitted their reports for MLEC stocks, with ROTH MKM repeating the rating for MLEC by listing it as a “Buy.” The predicted price for MLEC in the upcoming period, according to ROTH MKM is $5 based on the research report published on September 27, 2023 of the previous year 2023.
MLEC Trading at 9.19% from the 50-Day Moving Average
After a stumble in the market that brought MLEC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -60.91% of loss for the given period.
Volatility was left at 9.08%, however, over the last 30 days, the volatility rate increased by 9.23%, as shares surge +20.13% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.86% lower at present.
During the last 5 trading sessions, MLEC rose by +55.46%, which changed the moving average for the period of 200-days by -42.90% in comparison to the 20-day moving average, which settled at $1.3302. In addition, Moolec Science SA saw -30.09% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for MLEC
Current profitability levels for the company are sitting at:
- -3.1 for the present operating margin
- 0.03 for the gross margin
The net margin for Moolec Science SA stands at -19.91. The total capital return value is set at -0.82.
Based on Moolec Science SA (MLEC), the company’s capital structure generated 0.24 points at debt to capital in total, while cash flow to debt ratio is standing at -3.35. The debt to equity ratio resting at 0.31. The interest coverage ratio of the stock is -82.51.
Currently, EBITDA for the company is -52.08 million with net debt to EBITDA at -0.04. When we switch over and look at the enterprise to sales, we see a ratio of 23.7. The receivables turnover for the company is 1.46for trailing twelve months and the total asset turnover is 0.12. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.26.
Conclusion
In conclusion, Moolec Science SA (MLEC) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
